Francis Johns, MD
Plastic and Reconstructive Surgery · Greensburg, PANPI 1376574152
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $10,259 of the $11,667 with a category attached, or 87.9%. AbbVie accounts for 89.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $10,705 and has fallen 99.7% since, to $36 in 2025.
Across 36 payments — averaging $324.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Sientra, Inc.$864
- Acelrx Pharmaceuticals, Inc.$110
- Revance Therapeutics, Inc.$85
- Pacira Pharmaceuticals Incorporated$76
- Mentor Worldwide LLC$36
- plus $59 from 3 others
What the payments were for
- Food & beverage$1,40812%
- Gifts$10,25988%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $10,438 |
| Sientra, Inc. | 8 | $864 |
| Acelrx Pharmaceuticals, Inc. | 6 | $110 |
| Revance Therapeutics, Inc. | 1 | $85 |
| Pacira Pharmaceuticals Incorporated | 4 | $76 |
| Mentor Worldwide LLC | 2 | $36 |
| Medline Industries LP | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,667 in reported general payments places this provider in the 85th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.
See all plastic and reconstructive surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Scopolamine | 91 | $1,120 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 122 | $911 |
| Cefadroxil | 143 | $609 |
| Cyclobenzaprine Hcl | 68 | $294 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 56 | $236 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $149 |
| Clindamycin Hcl | 18 | $122 |
| Doxycycline Hyclate | 14 | $45 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Greensburg
- Theodore LazzaroGreensburg$2K
- Joseph SerlettiPhiladelphia$378K
- Chien-Wei LiaoPhiladelphia$131K
- Tobias LongLancaster$109K
- Louis BuckyArdmore$87K
- Kamran ShayestehJohnstown$47K
- Francis ColliniShavertown$45K
- John SchantzLancaster$35K
- Dinakar GollaPittsburgh$28K
- Johanna D'agostinoMechanicsburg$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.